Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

Details for Australian Patent Application No. 2006334732 (hide)

Owner POXEL SAS

Inventors Cravo, Daniel; Moinet, Gerard

Agent Davies Collison Cave

Pub. Number AU-B-2006334732

PCT Pub. Number WO2007/079915

Priority 06/00347 13.01.06 FR

Filing date 18 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 17 May 2012

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/079915 Priority application(s): WO2007/079915

16 July 2009 Assignment before Grant

  Merck Patent GmbH The application has been assigned to POXEL SAS

17 May 2012 Application Accepted

  Published as AU-B-2006334732

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006334733-Combination of triazine derivatives and HMG-COA reductase inhibitors for the treatment of diabetes

2006334731-Combination of triazine derivatives and insulin secretion stimulators